The round was led by The Capital Partnership and joined by Cormorant Asset Management and Shifamed Angels, the Campbell, Calif.-based incubator said. The round officially closed on April 25.
Supira Medical is developing a next-generation percutaneous ventricular assist device intended for use in high-risk patients undergoing interventional procedures, and is being run by Jean Orth in Shifamed’s Silicon Valley facilities.
“I am delighted Jean will lead the Supira team and spearhead the company’s early development efforts. The closing of this significant round of early-stage financing is a testimony to the large, unmet clinical need Supira’s technology will address. Jean’s 25+ years of cardiology-centric medical device experience, which includes her previous role as Executive VP of Business Development at Shifamed, makes her an ideal fit for Supira at this important time,” Shifamed founder & Supira chair Amr Salahieh said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.